Reports for BAUSCH HEALTH, CANADA INC.
Company Name
BAUSCH HEALTH, CANADA INC.
Totals |
||
Shortage reports |
346 |
|
| Actual shortage: | 11 (3%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 34 (10%) | |
| Resolved: | 301 (87%) | |
Discontinuation Reports |
13 |
|
| To be discontinued: | 1 (8%) | |
| Discontinued: | 12 (92%) | |
| Reversed: | 0 (0%) | |
Late reports |
96 (27%) |
|
Overdue reports |
2 (17%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ROFACT | 300MG | CAPSULE | Resolved | 2018-10-29 | 2019-08-01 | 65751 |
| ROFACT | 300MG | CAPSULE | Resolved | 2019-09-06 | 2020-03-18 | 93246 |
| ROFACT | 300MG | CAPSULE | Resolved | 2022-12-02 | 2023-02-24 | 176953 |
| ROFACT | 300MG | CAPSULE | Resolved | 2024-03-18 | 2024-04-17 | 222584 |
| ROFACT | 150MG | CAPSULE | Resolved | 2017-03-17 | 2017-06-16 | 3290 |
| ROFACT | 150MG | CAPSULE | Resolved | 2017-05-26 | 2017-06-16 | 11360 |
| ROFACT | 150MG | CAPSULE | Resolved | 2019-09-06 | 2020-03-18 | 93236 |
| ROFACT | 150MG | CAPSULE | Resolved | 2020-06-03 | 2020-07-27 | 116496 |
| ROFACT | 150MG | CAPSULE | Resolved | 2022-12-07 | 2023-02-24 | 177254 |
| CUPRIMINE | 250mg | Capsule | Resolved | 2017-03-14 | 2017-08-17 | 2263 |
| CUPRIMINE | 250MG | CAPSULE | Resolved | 2018-09-18 | 2018-12-22 | 61800 |
| CUPRIMINE | 250MG | CAPSULE | Resolved | 2022-08-03 | 2022-09-01 | 166020 |
| CUPRIMINE | 250MG | CAPSULE | Resolved | 2023-05-11 | 2023-07-10 | 192293 |
| CUPRIMINE | 250MG | CAPSULE | Resolved | 2023-10-06 | 2023-12-15 | 206596 |
| CARBOLITH | 150MG | CAPSULE | Resolved | 2020-04-01 | 2020-05-01 | 110364 |
| VIRAZOLE | 6G | AEROSOL POWDER FOR SOLUTION | Resolved | 2021-02-26 | 2021-08-12 | 134795 |
| VIRAZOLE | 6G | POWDER FOR SOLUTION AEROSOL | Resolved | 2022-02-17 | 2022-09-27 | 155206 |
| VIRAZOLE | 6G | POWDER FOR SOLUTION AEROSOL | Resolved | 2023-06-08 | 2023-11-01 | 193926 |
| VIRAZOLE | 6G | POWDER FOR SOLUTION AEROSOL | Resolved | 2023-12-15 | 2024-01-29 | 213468 |
| ARISTOCORT R | 0.1% | OINTMENT | Resolved | 2017-11-17 | 2017-12-01 | 29518 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| VITAMIN A ACID | 0.01% | GEL | To be discontinued | 2024-01-30 | 2024-01-30 | 217835 |
| VITAMIN A ACID | 0.05% | GEL | Discontinued | 2024-01-30 | 2024-02-08 | 217843 |
| DELATESTRYL | 200MG | SOLUTION | Discontinued | 2024-03-11 | 2024-04-26 | 221772 |
| VITAMIN A ACID | 0.025% | GEL | Discontinued | 2024-01-30 | 2024-02-08 | 217848 |
| THEOLAIR | 80MG | SOLUTION | Discontinued | 2021-04-26 | 2021-04-27 | 138081 |
| LIDEX | 0.05% | CREAM | Discontinued | 2023-12-08 | 2023-12-08 | 212804 |
| AIROMIR | 100MCG | METERED-DOSE AEROSOL | Discontinued | 2023-11-29 | 2023-11-29 | 211859 |
| ALTACE HCT | 12.5MG 2.5MG | TABLET | Discontinued | 2023-12-21 | 2024-01-09 | 214011 |
| ALTACE HCT | 12.5MG 5MG | TABLET | Discontinued | 2023-12-21 | 2024-01-09 | 214014 |
| ALTACE HCT | 12.5MG 10MG | TABLET | Discontinued | 2023-12-21 | 2024-01-09 | 214024 |
| ALTACE HCT | 25MG 5MG | TABLET | Discontinued | 2023-12-21 | 2024-01-09 | 214017 |
| ALTACE HCT | 25MG 10MG | TABLET | Discontinued | 2023-12-21 | 2024-01-09 | 214027 |
| LODALIS | 3.75G | POWDER FOR SUSPENSION | Discontinued | 2023-12-08 | 2024-02-20 | 212799 |
Showing 1 to 13 of 13